文献速递冠心病心力衰竭与心肌病

糖尿病缺血性心力衰竭中脂肪细胞小细胞外囊泡表面脂联素介导的心肌通讯机制

Small Extracellular Vesicle External Surface Adiponectin-Mediated Adipocytes/Cardiomyocytes Communication in Diabetic Ischemic Heart Failure.
PubMed 文献 · Circulation · 2026-03-02

该研究分离非糖尿病动物附睾脂肪垫的小细胞外囊泡(sEVs),在心肌梗死小鼠模型中进行心肌内注射。结果显示sEVs可减轻非糖尿病小鼠梗死后心脏重构并改善心功能,但对糖尿病心脏无保护作用。机制上,sEVs外表面富集脂联素(APN),通过心肌AdipoR1信号发挥保护效应,而糖尿病通过GRK2介导的AdipoR1磷酸化阻断该通讯通路。

要点

  • 脂肪细胞来源sEVs外表面富集脂联素,通过心肌AdipoR1介导心肌保护作用
  • 糖尿病心脏GRK2表达升高,磷酸化AdipoR1使其失活,阻断sEVs保护信号
  • 恢复AdipoR1功能可挽救糖尿病小鼠中sEVs的心肌保护效应

核心结论

  • 脂联素富集于脂肪细胞来源sEVs外表面且具有生物活性,在脂肪细胞-心肌细胞通讯中发挥关键作用
  • 糖尿病通过增强GRK2介导的AdipoR1磷酸化,破坏sEVs信号传导,加重缺血性心力衰竭

研究设计与样本

  • sEVs分离自非糖尿病动物附睾脂肪垫,心肌内注射至接受90分钟心肌梗死加4周再灌注的非糖尿病或糖尿病小鼠心脏
  • 使用APN敲除小鼠、APN中和抗体预处理sEVs、AdipoR1缺陷小鼠及GRK2过表达小鼠进行机制验证
  • 通过AAV9介导基因递送敲入磷酸化抵抗型突变AdipoR1(AdipoR1S205A)以恢复糖尿病小鼠AdipoR1功能

主要发现

  • sEVs处理显著减轻非糖尿病小鼠梗死后心脏重构并改善心功能,但糖尿病心脏未见保护效应
  • sEVs在15分钟内激活非糖尿病心肌细胞的ERK、AMPK和ACC激酶,并抑制氧化应激诱导的细胞死亡
  • Exo-Flow检测显示脂联素富集于sEVs外表面
  • APN敲除小鼠来源sEVs或APN中和抗体预处理sEVs均无法保护心脏免受缺血性心力衰竭
  • AdipoR1缺陷小鼠或GRK2过表达小鼠中sEVs的心脏保护效应消失

临床怎么用

  • 脂肪细胞来源sEVs外表面脂联素是潜在的心肌保护信号载体,但其在糖尿病患者中因AdipoR1失活而失效
  • 靶向GRK2-AdipoR1磷酸化轴或恢复AdipoR1功能可能是糖尿病缺血性心力衰竭的治疗方向

局限性

  • 研究基于动物模型,sEVs的保护效应及AdipoR1恢复策略尚需在人类糖尿病缺血性心力衰竭中验证

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mortality from acute myocardial infarction (MI) has declined significantly in the past decade for nondiabetic patients. However, both morbidity and mobility of ischemic heart failure (IHF) persistently escalate in the diabetic population via incompletely understood mechanisms. Recent studies demonstrated that small extracellular vesicles (sEVs) released from nondiabetic and diabetic adipocytes (ADps) exert opposite effects on acute myocardial ischemia and reperfusion (MI/R) injury. However, whether and how ADp sEVs may protect against post-MI remodeling and IHF, and more important, whether and how diabetes may impair this protective effect, remain unknown. METHODS: sEVs were isolated from epididymal fat pads of nondiabetic animals and intramyocardially injected in nondiabetic or diabetic hearts subjected to MI (90 minutes of MI per 4 weeks of reperfusion). RESULTS: sEV treatment significantly attenuated post-MI cardiac remodeling and improved cardiac function in nondiabetic mice. However, the protection was not observed in diabetic hearts. In adult cardiomyocytes isolated from nondiabetic hearts, sEVs rapidly (15 minutes) activated cell salvage kinases (ERK [extracellular signal-regulated kinase], AMPK [AMP-activated protein kinase], and ACC [acetyl-CoA carboxylase]) and suppressed oxidative stress-induced cell death, suggesting sEV external surface molecules are responsible for the observed cytoprotection. The Exo-Flow (a technology detecting sEV external surface molecules) demonstrated that adiponectin (APN) is enriched on the sEV external surface. The sEVs from APN knockout mice or APN neutralization (NU) antibody pretreated sEVs failed to protect the heart against IHF. Moreover, the cardioprotective effects of sEVs were abolished in APN receptor-1 (AdipoR1)-deficient mice (the primary receptor for APN signaling in the heart) or in mice overexpressing GRK2 (G-protein-coupled receptor kinase 2, a kinase that phosphorylates and inactivates AdipoR1). Finally, diabetes significantly increased cardiac GRK2 expression and AdipoR1 phosphorylation, which prevented sEVs from exerting their beneficial effects. Restoring AdipoR1 function by knockin a mutated phosphorylation-resistant AdipoR1 (AdipoR1S205A) via AAV9 (adeno-associated virus 9)-mediated gene delivery rescued ADp sEV cardioprotection in diabetic mice. CONCLUSIONS: Our study reveals that APN is enriched on the ADp-derived external surface of sEVs and is biologically active, playing a critical role in ADp-cardiomyocyte communication. Diabetes disrupts this communication by enhancing GRK2-mediated AdipoR1 phosphorylation, impairing sEV signaling, and exacerbating IHF. These findings provide new insights into the pathophysiology and therapy of IHF in diabetes.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Zhang, Zhu, Liu, et al. Small Extracellular Vesicle External Surface Adiponectin-Mediated Adipocytes/Cardiomyocytes Communication in Diabetic Ischemic Heart Failure. Circulation. 2026. PMID: 41766527. doi:10.1161/CIRCULATIONAHA.125.076372

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。